Discontinuation report BACITRACIN USP

Last updated on 2021-04-01 History
Report ID 135983
Drug Identification Number 00030708
Brand name BACITRACIN USP
Common or Proper name BACITRACIN USP
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BACITRACIN
Strength(s) 50000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL
Packaging size 5 x 30mL vial
ATC code J01XX
ATC description OTHER ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-03-31
Remaining supply date 2021-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-04-01 English Compare
v2 2021-03-18 French Compare
v1 2021-03-18 English Compare